Medicare Enrolled
Dr. Rafia Khalil, MD
Rheumatology · Port Huron, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khalil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khalil?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khalil
Dr. Rafia Khalil is a rheumatology specialist in Port Huron, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Khalil performed 45,395 Medicare services across 1,363 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khalil received a total of $27,205 from 42 pharmaceutical and/or device companies across 859 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khalil is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in MI
$27,205 industry payments
Medicare Practice Summary
Medicare Utilization ↗45,395
Medicare services
Top 8% in MI for rheumatology
1,363
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,270 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
24,550 | $34 | $90 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
15,250 | $11 | $72 |
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $33 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,250 | $1 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
823 | $85 | $136 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
576 | $90 | $320 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
153 | $50 | $115 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
118 | $20 | $125 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
108 | $28 | $65 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
101 | $38 | $207 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
95 | $64 | $165 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
94 | $108 | $209 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $58 | $92 |
| Injection of carpal tunnel | 62 | $52 | $105 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
58 | $4 | $27 |
| Wrist X-ray, minimum 3 views An imaging test using X-rays to capture at least three different angles of the wrist bones and joints. |
55 | $39 | $56 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
54 | $34 | $48 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
51 | $20 | $80 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
44 | $41 | $195 |
| Ultrasound-guided joint aspiration or injection Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement. |
42 | $59 | $143 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
33 | $31 | $46 |
| Ankle X-ray, minimum 3 views An X-ray imaging test of the ankle that captures at least three different angles to evaluate the bones and joints. |
29 | $35 | $50 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
28 | $25 | $99 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
25 | $38 | $56 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
23 | $18 | $50 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
23 | $24 | $117 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
20 | $34 | $77 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
18 | $31 | $72 |
| Lower back and sciatic nerve injection An injection of an anesthetic and/or steroid medication into the lower back and sciatic nerve. This procedure delivers medication directly to the nerve site. |
16 | $121 | $183 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
89.1% high complexity
8.2% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$27,205
Total received (2018-2024)
Avg $3,886/year across 7 years
Top 14% in MI for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
859
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,237 (52.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,968 (47.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,965
2023
$2,158
2022
$1,720
2021
$1,760
2020
$1,469
2019
$5,795
2018
$11,339
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$572
Amgen Inc.
$545
Janssen Biotech, Inc.
$330
E.R. Squibb & Sons, L.L.C.
$252
ANI Pharmaceuticals, Inc.
$240
PFIZER INC.
$233
Fresenius Kabi USA, LLC
$138
Novartis Pharmaceuticals Corporation
$113
UCB, Inc.
$112
SOBI, INC
$65
Alexion Pharmaceuticals, Inc.
$61
Aurinia Pharma U.S., Inc.
$59
GENZYME CORPORATION
$56
GlaxoSmithKline, LLC.
$52
Organon Llc
$47
Fidia Pharma USA Inc.
$31
AstraZeneca Pharmaceuticals LP
$25
Genentech USA, Inc.
$21
Actelion Pharmaceuticals US, Inc.
$14
Top 3 companies account for 48.8% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$14,158
Amgen Inc.
$1,837
Janssen Biotech, Inc.
$1,821
ABBVIE INC.
$1,315
UCB, Inc.
$1,223
PFIZER INC.
$1,079
E.R. Squibb & Sons, L.L.C.
$937
Novartis Pharmaceuticals Corporation
$784
AbbVie Inc.
$438
Horizon Therapeutics plc
$303
Regeneron Healthcare Solutions, Inc.
$261
Lilly USA, LLC
$258
ANI Pharmaceuticals, Inc.
$255
AstraZeneca Pharmaceuticals LP
$241
Genentech USA, Inc.
$229
GlaxoSmithKline, LLC.
$214
Actelion Pharmaceuticals US, Inc.
$186
GENZYME CORPORATION
$179
Sobi, Inc
$142
Fresenius Kabi USA, LLC
$138
SOBI, INC
$134
Alexion Pharmaceuticals, Inc.
$122
Mallinckrodt Enterprises LLC
$117
Flexion Therapeutics, Inc.
$108
Aurinia Pharma U.S., Inc.
$107
Organon LLC
$79
Janssen Scientific Affairs, LLC
$63
Fidia Pharma USA Inc.
$62
Exeltis, USA Inc.
$56
Radius Health, Inc.
$52
Horizon Pharma plc
$50
Organon Llc
$47
Mallinckrodt Hospital Products Inc.
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Antares Pharma, Inc.
$25
Mylan Institutional Inc.
$22
SANOFI-AVENTIS U.S. LLC
$18
Biocon Biologics Inc
$17
Celgene Corporation
$17
Mallinckrodt LLC
$16
Bioventus LLC
$14
MEDAC PHARMA, INC.
$14
Top 3 companies account for 65.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · DARZALEX · Durolane · EVENITY · EVUSHELD · Enbrel · HADLIMA · HUMIRA · HYMOVIS · Hulio · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNAGIS · SYNVISC-ONE · Strensiq · TALTZ · TAVNEOS · TREMFYA · TRILURON · Tavneos · Tymlos · UPTRAVI · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Rheumatologists within 10 mi
2
Per 100K population
1.2
County median income
$69,349
Nearest hospital
LAKE HURON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khalil is a mixed practice specialist, with above-average Medicare volume (top 8% in MI), with speaking/promotional industry engagement in the top 14% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khalil experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Khalil performed 24,550 abatacept infusion (orencia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khalil receive payments from pharmaceutical companies?
Yes. Dr. Khalil received a total of $27,205 from 42 companies across 859 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khalil's costs compare to other rheumatologists in Port Huron?
Dr. Khalil's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khalil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Port Huron
Browse rheumatologists in Port Huron ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in MI
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in MI
Which MI rheumatologists receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology